Amgen (AMGN) FCF Payout Ratio (2011 - 2026)
Amgen's quarterly FCF Payout Ratio came in at 0.92 in Q1 2026, down 29.55% year-on-year from 1.31 in Q1 2025, and down 31.13% quarter-over-quarter from 1.34 in Q4 2025.
Amgen has reported FCF Payout Ratio for 16 years, with the latest figure at 0.92 in Q1 2026.
- For the quarter ending Q1 2026, FCF Payout Ratio fell 29.55% year-over-year to 0.92; the trailing twelve-month figure through Mar 2026 stood at 0.61 (up 34.73% YoY), and the FY2025 full-year result was 0.63, up 36.08% from the prior year.
- FCF Payout Ratio for Q1 2026 stood at 0.92, down from 1.34 in the prior quarter.
- The five-year high for FCF Payout Ratio was 3.94 in Q4 2023, with the low at 0.27 in Q4 2024.
- Average FCF Payout Ratio over 5 years is 0.98, with a median of 0.55 recorded in 2022.
- Year-over-year, FCF Payout Ratio surged 775.79% in 2023 and slumped 93.06% in 2024.
- Tracing AMGN's FCF Payout Ratio over 5 years: stood at 0.45 in 2022, then surged by 775.79% to 3.94 in 2023, then tumbled by 93.06% to 0.27 in 2024, then surged by 387.49% to 1.34 in 2025, then tumbled by 31.13% to 0.92 in 2026.
- The last three FCF Payout Ratio figures came in at 0.92 (Q1 2026), 1.34 (Q4 2025), and 0.3 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 0.51 |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 2.14 |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 0.87 |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 0.72 |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 0.92 |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 0.43 |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 1.12 |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 1.69 |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.92 |
| Dec 31, 2025 | 1.34 |
| Sep 30, 2025 | 0.30 |
| Jun 30, 2025 | 0.67 |
| Mar 31, 2025 | 1.31 |
| Dec 31, 2024 | 0.27 |
| Sep 30, 2024 | 0.37 |
| Jun 30, 2024 | 0.54 |
| Mar 31, 2024 | 2.63 |
| Dec 31, 2023 | 3.94 |
| Sep 30, 2023 | 0.45 |
| Jun 30, 2023 | 0.30 |
| Mar 31, 2023 | 1.58 |
| Dec 31, 2022 | 0.45 |
| Sep 30, 2022 | 0.37 |
| Jun 30, 2022 | 0.62 |
| Mar 31, 2022 | 0.55 |
| Dec 31, 2021 | 0.39 |
| Sep 30, 2021 | 0.46 |
| Jun 30, 2021 | 0.58 |
| Mar 31, 2021 | 0.52 |
| Dec 31, 2020 | 0.47 |
| Sep 30, 2020 | 0.29 |
| Jun 30, 2020 | 0.35 |
| Mar 31, 2020 | 0.47 |
| Dec 31, 2019 | 0.37 |
| Sep 30, 2019 | 0.27 |
| Jun 30, 2019 | 0.69 |
| Mar 31, 2019 | 0.52 |
| Dec 31, 2018 | 0.28 |
| Sep 30, 2018 | 0.27 |
| Jun 30, 2018 | 0.45 |
| Mar 31, 2018 | 0.37 |
| Dec 31, 2017 | 0.29 |
| Sep 30, 2017 | 0.25 |
| Jun 30, 2017 | 0.40 |
| Mar 31, 2017 | 0.38 |
| Dec 31, 2016 | 0.26 |
| Sep 30, 2016 | 0.30 |
| Jun 30, 2016 | 0.30 |
| Mar 31, 2016 | 0.43 |
| Dec 31, 2015 | 0.32 |
| Sep 30, 2015 | 0.22 |
| Jun 30, 2015 | 0.19 |
| Mar 31, 2015 | 0.44 |
| Dec 31, 2014 | 0.18 |
| Sep 30, 2014 | 0.18 |
| Jun 30, 2014 | 0.23 |
| Mar 31, 2014 | 0.47 |
| Dec 31, 2013 | 0.22 |
| Sep 30, 2013 | 0.22 |
| Jun 30, 2013 | 0.25 |
| Mar 31, 2013 | 0.40 |
| Dec 31, 2012 | 0.45 |
| Sep 30, 2012 | 0.18 |
| Jun 30, 2012 | 0.13 |
| Mar 31, 2012 | 0.34 |
| Dec 31, 2011 | 0.18 |
| Sep 30, 2011 | 0.30 |